Mortality falls with dexamethasone WHO "very welcome news" June 18, 6:00
WHO = The World Health Organization welcomes the announcement of a research team in the United Kingdom that existing drugs that suppress inflammation have been effective in severely ill patients with the new coronavirus, and will include them in future treatment guidelines. I made clear my thoughts.
A research team at Oxford University in the United Kingdom announced on the 16th that the mortality rate decreased as a result of administering a drug called dexamethasone, one of the steroids that suppress inflammation, to multiple severely ill patients.
On this, WHO Executive Secretary Tedros said in a regular press conference yesterday, "It's very welcome news for critically ill patients. We have begun to analyze data from various clinical trials to better understand treatment with this drug. He added that he will make it into the guidebook for the treatment of new coronavirus in the future.
In addition, regarding the therapeutic drug "hydroxychloroquine" for malaria that has been revoked in the US, Henna Orestrepo, head of WHO's research and development team, said, "Various research results have been used to treat new coronaviruses. It suggests that it will not reduce the number of people who die," he said, discontinuing the clinical trials that WHO has been conducting.